Sidney Clevinger, M.D. Joins BioRegenerative Sciences as Medical Director

San Diego, CA, May 25, 2011 --(PR.com)-- BioRegenerative Sciences, Inc., a privately owned stem cell therapeutics corporation headquartered in San Diego, CA, USA, announced today that Sidney Clevinger, M.D. has joined BRS’s executive management as Medical Director. Dr. Clevinger received his training in New York and has been in private practice for over 20 years. The private practice of Dr. Clevinger has included his developing and operating several regional clinics in the State of Florida where he has been involved in numerous medical activities, including the performance of numerous clinical trials for drug development. Paul Franck, R.Ph., cofounder and COO of BRS, said that “I have known and worked closely with Dr. Clevinger on several projects during the last two decades, and Sid brings a wealth of experience and leadership skills within the realm of medical science, entrepreneurship in the medical field, and delivering quality medical care to patients. Dr. Clevinger will bring important medial leadership to BRS as we move forward with development and commercialization of our therapeutic products and services.” Dr. Greg Maguire, cofounder and CEO of BioRegnerative Sciences, also commented on Dr. Clevinger’s appointment as medical director, “We are excited that Dr. Clevinger has joined BRS to bring leadership in the development of our therapeutics and therapeutic services. Sidney understands very well how to deliver excellent patient care through his years of successful experience as a practicing physician, the entrepreneurial process as founder of several regional clinics, and the development of therapeutics as a clinical research scientist involved in numerous drug approvals. BRS is fortunate to have Dr. Clevinger join us, especially during BRS’s rapid development phase as an emerging biotechnology corporation.”

BioRegenerative Sciences, Inc. currently has eight products on the market and is further developing a portfolio of therapeutic and cosmeceutical products and services based on BRS’s core stem cell-based S2RM Technology.TM For more information, please email: sales@bioregenerativesciences.com, or call customer service at 877.892.9991.

###